Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
This study has been completed.
Study NCT00004353   Information provided by National Center for Research Resources (NCRR)
First Received: October 18, 1999   Last Updated: July 9, 2008   History of Changes

October 18, 1999
July 9, 2008
December 1978
 
 
 
Complete list of historical versions of study NCT00004353 on ClinicalTrials.gov Archive Site
 
 
 
Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
 

OBJECTIVES: I. Study the metabolism of pyruvate and related problems in patients with lactic acidemia.

II. Define the nature of the metabolic defect.

PROTOCOL OUTLINE: Patients fast for 6 hours. Glucagon IM is administered after the 6 hour fast. Glucose level is measured at 0, 15, 30, 45, 60, and 90 minutes.

In children of sufficient size, alanine and lactic acid should also be measured at each or most of these time points.

Fasting continues for at least 18 hours. Glucagon IM is administered again at end of fast. Glucose level is measured at time 0, 15, 30, 45, 60, and 90 minutes.

 
Observational
 
  • Mitochondrial Myopathy
  • MELAS Syndrome
  • Lactic Acidosis
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
35
 
 

PROTOCOL ENTRY CRITERIA:

  • Diagnostically documented elevation in lactate, pyruvate, and/or alanine levels in lactic acidemia patients
Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00004353
 
NCRR-M01RR00827-0071, UCSD-071
National Center for Research Resources (NCRR)
University of California, San Diego
Study Chair: Richard H. Haas University of California, San Diego
National Center for Research Resources (NCRR)
April 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP